Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells : implications for their infusion across major HLA barriers

29 References

SANGIOLO Dario

Department of Oncological Sciences, University of Torino Medical School
MARTINUZZI Emanuela

Laboratory of Cancer Immunology, Institute for Cancer Research and Treatment
TODOROVIC Maja

Laboratory of Cancer Immunology, Institute for Cancer Research and Treatment
VITAGGIO Katiuscia

Department of Oncological Sciences, University of Torino Medical School
VALLARIO Antonella

Laboratory of Cancer Immunology, Institute for Cancer Research and Treatment
JORDANEY Noela

Division of Medical Oncology, Institute for Cancer Research and Treatment
CARNEVALE-SCHIANCA Fabrizio

Division of Medical Oncology, Institute for Cancer Research and Treatment
CAPALDI Antonio

Division of Medical Oncology, Institute for Cancer Research and Treatment
GEUNA Massimo

Laboratory of Clinical and Experimental Cytometry, Institute for Cancer Research and Treatment
CASORZO Laura

Unit of Pathology, Institute for Cancer Research and Treatment
NASH Richard A.

Fred Hutchinson Cancer Research Center and University of Washington Medical School
AGLIETTA Massimo

Department of Oncological Sciences, University of Torino Medical School
CIGNETTI Alessandro

Laboratory of Cancer Immunology, Institute for Cancer Research and Treatment

Search this article